⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC)
halaven.com · Healthcare
Somewhat visible. AI bots can read HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC), but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 1 times
Claude
#42,675 of 834,343 in Healthcare for AI visibility
6.1
/10
AEO Score
About HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC)
from our crawl and measurement
HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC) is a business whose own site puts it this way: "Learn about HALAVEN® (eribulin mesylate), an injectable treatment for patients with third-line Metastatic Breast Cancer (mBC)." Its AI visibility score is 6.1 out of 10: the engines can find it, but they do not have much to hold on to.
Our crawl found a sitemap. It is missing structured data describing the business, an llms.txt file and a heading structure that lays out what it offers.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Higher is better · 0-10
Structured Data
2
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
10
Clear headings and answer-style content.
Entity Clarity
6
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
5
Experience, Expertise, Authority, Trust markers.
Technical AEO
7
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
7
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
9
Inbound links from other sites.
Domain Authority
3
Established authority for your domain.
Reference Presence
0
Not in AI knowledge graphs yet.
News & Press
0
No press coverage found yet.
Community
0
No community discussion yet.
Social Mentions
0
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 6.1/10, HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC) has a working base to build on - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC)
Which AI engines already crawl you
Weekly ChatGPT & Claude citation tracking
The AEO Checklist Every Small Business Owner Needs Right Now
Your potential customers are asking ChatGPT, Gemini, and Claude questions about your product category. These AI models are giving answers without sending traffic to your website. You're not losing rank. You're losing visibility entirely.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC).
Source & Attribution
Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/halaven
Cite this score: Engagemii (2026). "AEO Score for HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC)." Retrieved from https://engagemii.com/aeo/brands/halaven
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform